Skip to main content

Advertisement

SpringerLink
Log in

Apoptosis and apoptosis related proteins in chronic viral liver disease

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Background: Apoptosis may be an important mechanism of hepatocyte death in chronic viral liver disease.

Methods: We studied apoptosis in liver biopsies from 30 patients with chronic viral hepatitis and 8 patients with viral cirrhosis by the TUNEL method. 12 cases of non-alcoholic steatohepatitis and 12 cases of primary biliary cirrhosis were used as non-viral disease controls. Immunohistochemical expression of p53, p21/waf1, bcl-2 and mdm-2 proteins was also studied in the same patients.

Results: A statistically significant increase of apoptotic liver cells was found in severe chronic viral hepatitis (5.3 ± 0.3%), cirrhosis (3.4 ± 0.5%) and PBC (4.4 ± 0.4%) cases compared to patients with non-alcoholic steatohepatitis (0.8 ± 0.3%). The expression of p53 protein was increased in the cases of viral cirrhosis and in chronic severe viral hepatitis whereas in the cases of chronic mild hepatitis, PBC and non-alcoholic steatohepatitis we found no expression of p53. P21/waf1 expression was increased in severe chronic hepatitis, cirrhosis and PBC cases compared to mild hepatitis and non-alcoholic steatohepatitis cases. However no induction of mdm-2 was observed in the subgroups of chronic liver disease. Bcl-2 was expressed only in epithelium of bile ducts and mononuclear cells of the portal tracts and liver lobules. A weaker Bcl-2 expression was noted in the epithelium of bile ducts of 7/12 PBC cases.

Conclusion: Our results provide evidence of increased apoptosis in severe chronic viral liver disease, suggesting that apoptotic cell death might be involved in the pathogenesis of hepatocellular damage of viral hepatitis and cirrhosis. Furthermore we analysed part of the apoptotic pathways implicated in the above process and found an increased expression of p21/waf1, probably p53 mediated, without overexpression of the apoptosis inhibiting bcl-2 and mdm-2 proteins. By contrast p21/waf1 overexpression in PBC seems to be propagated by a p53 independent mechanism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hayashi N, Mita E. Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis. J Viral Hepat 1999; 6: 357–365.

    Google Scholar 

  2. Luo KX, Zhu YF, Zhang LX, He HT, Wang XS, Zhang L. In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases. J Viral Hepat 1997; 4: 303–307.

    Google Scholar 

  3. Ando K, Hiroishi K, Kaneko T, et al. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 1997; 158: 5283–5291.

    Google Scholar 

  4. Rosser BG, Gores GJ. Liver cell necrosis: Cellular mechanisms and clinical implications. Gastroenterology 1995; 108: 252–275.

    Google Scholar 

  5. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–257.

    Google Scholar 

  6. Fawthrop DJ, Boobis AR, Davies DS. Mechanisms of cell death. Arch Toxicol 1991; 65: 437–444.

    Google Scholar 

  7. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997; 99: 1472–1477.

    Google Scholar 

  8. Kagi D, Vignaux F, Ledermann B, et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265: 528–530.

    Google Scholar 

  9. Hiramatsu N, Hayashi N, Katayama K, et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994; 19: 1354–1359.

    Google Scholar 

  10. Ferenbach DA, Haydon GH, Rae F, Malcomson RD, Harrison DJ. Alteration in mRNA levels of Fas splice variants in hepatitis C-infected liver. J Pathol 1997; 183: 299–304.

    Google Scholar 

  11. Mochizuki K, Hayashi N, Hiramatsu N, et al. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 1996; 24: 1–7.

    Google Scholar 

  12. Galle PR, Hofmann WJ, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995; 182: 1223–1230.

    Google Scholar 

  13. Mita E, Hayashi N, Iio S, et al. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 1994; 204: 468–474.

    Google Scholar 

  14. Iio S, Hayashi N, Mita E, et al. Serum levels of soluble Fas antigen in chronic hepatitis C patients. J Hepatol 1998; 29: 517–523.

    Google Scholar 

  15. Seishima M, Takemura M, Saito K, Ando K, Noma A. Increased serum soluble Fas (sFas) concentrations in HCV-positive patients with liver cirrhosis. J Hepatol 1997; 27: 424–425.

    Google Scholar 

  16. Shimotohno K. Hepatitis C virus and its pathogenesis. Semin Cancer Biol 2000; 10: 233–240.

    Google Scholar 

  17. Ray RB, Meyer K, Ray R. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 1996; 226: 176–182.

    Google Scholar 

  18. Ray RB, Steele R, Meyer K, Ray R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 1997; 272: 10983–10986.

    Google Scholar 

  19. Ray RB, Steele R, Meyer K, Ray R. Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene 1998; 208: 331–336.

    Google Scholar 

  20. Zhu N, Khoshnan A, Schneider R, et al. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 1998; 72: 3691–3697.

    Google Scholar 

  21. Honda M, Kaneko S, Shimazaki T, et al. Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology 2000; 31: 1351–1359.

    Google Scholar 

  22. Lu W, Lo SY, Chen M, Wu Kj, Fung YK, Ou JH. Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology 1999; 264: 134–141.

    Google Scholar 

  23. Otsuka M, Kato N, Lan KH, et al. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J Biol Chem 2000; 275: 34122–34130.

    Google Scholar 

  24. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994; 91: 2230–2234.

    Google Scholar 

  25. Truant R, Antunovic J, Greenblatt J, Prives C, Cromlish JA. Direct interaction of the hepatitisBvirusHBxprotein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J Virol 1995; 69: 1851–1859.

    Google Scholar 

  26. Arbuthnot P, Capovilla A, Kew M. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J Gastroenterol Hepatol 2000; 15: 357–368.

    Google Scholar 

  27. Wang XW, Gibson MK, Vermeulen W, et al. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 1995; 55: 6012–6016.

    Google Scholar 

  28. Chirillo P, Pagano S, Natoli G, et al. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci USA 1997; 94: 8162–8167.

    Google Scholar 

  29. Acute and chronic hepatitis revisited. Review by an international group. Lancet 1977; 29: 914–919.

  30. Bianchi L, Gudat F. Chronic hepatitis. In: MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC, eds. Pathology of the Liver, 3rd ed. Edinburgh: Churchill Livingstone 1994: 359.

    Google Scholar 

  31. Scheuer PJ. Primary biliary cirrhosis. Proc Roy Soc Med 1967; 60: 1257–1260.

    Google Scholar 

  32. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493–501.

    Google Scholar 

  33. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219–229.

    Google Scholar 

  34. Avantaggiati ML, Natoli G, Balsano C, et al. The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements. Oncogene 1993; 8: 1567–1574.

    Google Scholar 

  35. Twu JS, Lai MY, Chen DS, Robinson WS. Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology 1993; 192: 346–350.

    Google Scholar 

  36. Balsano C, Avantaggiati ML, Natoli G, et al. Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the c-myc protooncogene at the transcriptional level. Biochem Biophys Res Commun 1991; 176: 985–992.

    Google Scholar 

  37. Menzo S, Clementi M, Alfani E, et al. Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. Virology 1993; 196: 878–882.

    Google Scholar 

  38. Doria M, Klein N, Lucito R, Schneider RJ. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J 1995; 14: 4747–4757.

    Google Scholar 

  39. Maguire HF, Hoeffler JP, Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by proteinprotein interactions. Science 1991; 252: 842–844.

    Google Scholar 

  40. Williams JS, Andrisani OM. The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. Proc Natl Acad Sci USA 1995; 92: 3819–3823.

    Google Scholar 

  41. Natoli G, Avantaggiati ML, Chirillo P, et al. Ras-and Rafdependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 1994; 9: 2837–2843.

    Google Scholar 

  42. Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 1993; 361: 742–745.

    Google Scholar 

  43. Benn J, Schneider RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 1994; 91: 10350–10354.

    Google Scholar 

  44. Chirillo P, Falco M, Puri PL, et al. Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Rafindependent pathway. J Virol 1996; 70: 641–646.

    Google Scholar 

  45. Terradillos O, Pollicino T, Lecoeur H, et al. P53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 1998; 17: 2115–2123.

    Google Scholar 

  46. Shintani Y, Yotsuyanagi H, Moriya K, et al. Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system. J Gen Virol 1999; 80: 3257–3265.

    Google Scholar 

  47. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note. Hepatology 1995; 21: 1465–1468.

    Google Scholar 

  48. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131–1141.

    Google Scholar 

  49. Kimura K, Sasano H, Shimosegawa T, et al. Ultrastructural and confocal laser scanning microscopic examination of TUNELpositive cells. J Pathol 1997; 181: 235–242.

    Google Scholar 

  50. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992; 69: 1237–1245.

    Google Scholar 

  51. Kronenberger B, Ruster B, Lee JH, et al. Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels. J Hepatol 2000; 33: 640–647.

    Google Scholar 

  52. Calabrese F, Pontisso P, Pettenazzo E, et al. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology 2000; 31: 1153–1159.

    Google Scholar 

  53. Crary GS, Albrecht JH. Expression of cyclin-dependent kinase inhibitor p21 in human liver. Hepatology 1998; 28: 738–743.

    Google Scholar 

  54. Ehrmann J, Galuszkova D, Krc I, et al. Apoptosis-related proteins, BCL-2, BAX, FAS, FAS-L and PCNA in liver biopsies of patients with chronic hepatitis B virus infection. Pathol Oncol Res 2000; 6: 130–135.

    Google Scholar 

  55. Ziol M, Tepper M, Lohez M, et al. Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol 2001; 34: 254–260.

    Google Scholar 

  56. Zhao M, Zhang NX, Economou M, Blaha I, Laissue JA, Zimmermann A. Immunohistochemical detection of bcl-2 protein in liver lesions: Bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopathology 1994; 25: 237–245.

    Google Scholar 

  57. Nakopoulou L, Stefanaki K, Vourlakou C, Manolaki N, Gakiopoulou H, Michalopoulos G. Bcl-2 protein expression in acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma. Pathol Res Pract 1999; 195: 19–24.

    Google Scholar 

  58. Owen-Schaub LB, Zhang W, Cusack JC, et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/ APO-1 expression. Mol Cell Biol 1995; 15: 3032–3040.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Medical School, University of Crete, Heraklion, Greece

    P. Papakyriakou, V. Valatas, G. Notas, C. Xidakis & E. Kouroumalis

  2. Department of Pathology, Medical School, University of Crete, Heraklion, Greece

    M. Tzardi, P. Kanavaros & E. Karydi

Authors
  1. P. Papakyriakou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Tzardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. Valatas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Kanavaros
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Karydi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Notas
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Xidakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. Kouroumalis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papakyriakou, P., Tzardi, M., Valatas, V. et al. Apoptosis and apoptosis related proteins in chronic viral liver disease. Apoptosis 7, 133–141 (2002). https://doi.org/10.1023/A:1014472430976

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1014472430976

Search

Navigation